↗2 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$13.1MSold on the market
1Companies
Sep 17, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 17, 202621:35 | Sep 16, 2026from Sep 15, 2026 | TVTXTravere Therapeutics, Inc. | Chief Research Officer | S · Sell10b5-1 | $62.83 | −209,048 | 98,197 | -68% | −$13.1M | ||
| Sep 17, 202621:35 | Sep 16, 2026from Sep 15, 2026 | TVTXTravere Therapeutics, Inc. | Chief Research Officer | M · Exercise10b5-1 | $21.41 | +191,500 | 211,047 | +980% | $4.1M |